Levetiracetam has a favorable pharmacology profile to be used subcutaneously. However, its subcutaneous use is still considered off-label as this is beyond its license. The evidence base for its safety, tolerability, and efficacy is limited to observational studies.
Tópico:
Epilepsy research and treatment
Citaciones:
1
Citaciones por año:
Altmétricas:
0
Información de la Fuente:
FuenteAmerican Journal of Hospice and Palliative Medicine®
